Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Genentech Eagerly Awaits FDA Word on 2nd Breast Cancer Drug
Genentech Eagerly Awaits FDA Word on 2nd Breast Cancer Drug
Genentech Eagerly Awaits FDA Word on 2nd Breast Cancer Drug
Submitted by
admin
on June 8, 2012 - 11:51am
Source:
Xconomy
News Tags:
FDA
breast cancer
Roche
Perjeta
Pertuzumab
Headline:
Genentech Eagerly Awaits FDA Word on 2nd Breast Cancer Drug
Do Not Allow Advertisers to Use My Personal information
